Compare SGI & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SGI | DGX |
|---|---|---|
| Founded | 1846 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 23.1B |
| IPO Year | N/A | 1996 |
| Metric | SGI | DGX |
|---|---|---|
| Price | $76.94 | $199.33 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 13 |
| Target Price | $96.17 | ★ $208.62 |
| AVG Volume (30 Days) | ★ 2.1M | 742.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 0.89% | ★ 1.71% |
| EPS Growth | N/A | ★ 13.78 |
| EPS | N/A | ★ 8.75 |
| Revenue | N/A | ★ $11,035,000,000.00 |
| Revenue This Year | $7.03 | $7.55 |
| Revenue Next Year | $5.10 | $3.75 |
| P/E Ratio | $48.98 | ★ $22.92 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $53.10 | $157.20 |
| 52 Week High | $98.56 | $213.50 |
| Indicator | SGI | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 31.01 | 48.01 |
| Support Level | $69.78 | $176.61 |
| Resistance Level | $87.44 | $213.35 |
| Average True Range (ATR) | 2.62 | 4.06 |
| MACD | -1.06 | -1.75 |
| Stochastic Oscillator | 3.43 | 18.47 |
Somnigroup International Inc is a bedding company, dedicated to improving people's lives through good sleep. With superior capabilities in design, manufacturing, distribution and retail, It delivers breakthrough sleep solutions and serves the evolving needs of consumers in more than 100 countries world-wide through its fully-owned businesses, Tempur Sealy, Mattress Firm and Dreams. The company's portfolio includes the brand such as Tempur-Pedic, Sealy and Stearns & Foster, and its Multinational omnichannel platform enables the company to meet consumers wherever shop, offering a personal connection and innovation to provide a retail experience and tailored solutions.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.